Paragon 28 Inc (FNA)
10.53
+0.76
(+7.78%)
USD |
NYSE |
May 03, 16:00
10.53
0.00 (0.00%)
After-Hours: 20:00
Paragon 28 SG&A Expense (Quarterly): 48.25M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 48.25M |
September 30, 2023 | 44.13M |
June 30, 2023 | 43.83M |
March 31, 2023 | 43.82M |
December 31, 2022 | 44.47M |
September 30, 2022 | 39.67M |
June 30, 2022 | 37.95M |
Date | Value |
---|---|
March 31, 2022 | 37.24M |
December 31, 2021 | 35.08M |
September 30, 2021 | 28.97M |
June 30, 2021 | 26.64M |
March 31, 2021 | 23.40M |
December 31, 2020 | 21.68M |
September 30, 2020 | 16.96M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
16.96M
Minimum
Sep 2020
48.25M
Maximum
Dec 2023
35.15M
Average
37.60M
Median
SG&A Expense (Quarterly) Benchmarks
Stryker Corp | 1.84B |
Alphatec Holdings Inc | 104.12M |
Globus Medical Inc | 244.72M |
Orthofix Medical Inc | 132.28M |
Sensus Healthcare Inc | 1.577M |